Atlas Trials

T-cell Childhood Acute Lymphoblastic Leukemia

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch T-cell Childhood Acute Lymphoblastic Leukemia

RecordFirmDate
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01088763)National Cancer Institute (NCI)2010-03-01
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT00873093)National Cancer Institute (NCI)2009-03-01
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01093586)Case Comprehensive Cancer Center2007-09-01
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission (NCT00382109)Children's Oncology Group2007-03-01
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT00101205)National Cancer Institute (NCI)2004-11-01
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate (NCT00898404)Children's Oncology Group2003-11-01
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00061945)National Cancer Institute (NCI)2003-06-01
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia (NCT00049569)National Cancer Institute (NCI)2003-01-01
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation (NCT00052520)Fred Hutchinson Cancer Center2002-09-01
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00016302)National Cancer Institute (NCI)2001-04-01
506U78 in Treating Patients With Refractory Hematologic Cancer (NCT00002970)National Cancer Institute (NCI)1997-06-01

Track T-cell Childhood Acute Lymphoblastic Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.